JP2023524434A5 - - Google Patents

Info

Publication number
JP2023524434A5
JP2023524434A5 JP2022565781A JP2022565781A JP2023524434A5 JP 2023524434 A5 JP2023524434 A5 JP 2023524434A5 JP 2022565781 A JP2022565781 A JP 2022565781A JP 2022565781 A JP2022565781 A JP 2022565781A JP 2023524434 A5 JP2023524434 A5 JP 2023524434A5
Authority
JP
Japan
Prior art keywords
cells
icam3
cov
sars
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022565781A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524434A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/029608 external-priority patent/WO2021222385A1/en
Publication of JP2023524434A publication Critical patent/JP2023524434A/ja
Publication of JP2023524434A5 publication Critical patent/JP2023524434A5/ja
Pending legal-status Critical Current

Links

JP2022565781A 2020-04-29 2021-04-28 新規療法 Pending JP2023524434A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063017199P 2020-04-29 2020-04-29
US63/017,199 2020-04-29
PCT/US2021/029608 WO2021222385A1 (en) 2020-04-29 2021-04-28 Glucocorticoid receptor (gr) modulators for treating a sars-cov-2 virus

Publications (2)

Publication Number Publication Date
JP2023524434A JP2023524434A (ja) 2023-06-12
JP2023524434A5 true JP2023524434A5 (cg-RX-API-DMAC7.html) 2024-05-08

Family

ID=76270026

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022565781A Pending JP2023524434A (ja) 2020-04-29 2021-04-28 新規療法

Country Status (7)

Country Link
US (1) US20230172950A1 (cg-RX-API-DMAC7.html)
EP (1) EP4142736A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023524434A (cg-RX-API-DMAC7.html)
KR (1) KR20230015927A (cg-RX-API-DMAC7.html)
CN (1) CN115666583A (cg-RX-API-DMAC7.html)
BR (1) BR112022021691A2 (cg-RX-API-DMAC7.html)
WO (1) WO2021222385A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021247000A1 (en) 2020-06-01 2021-12-09 Avm Biotechnology, Llc Methods of treatment using icam-modulating agents
EP4426317A1 (en) * 2021-11-05 2024-09-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of low molecular weight hyaluronic acid for the treatment of lung mucosal inflammation
CN114028571B (zh) * 2021-11-18 2023-04-28 中国医学科学院基础医学研究所 含氮双膦酸盐联合糖皮质激素在预防或治疗病毒性肺炎中的应用
CN114099481B (zh) * 2022-01-28 2022-05-24 深圳湾实验室 雾化吸入型糖皮质激素纳米药物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110475571B (zh) 2017-04-01 2023-04-04 Avm生物技术有限责任公司 细胞免疫疗法前细胞毒性预调理的替代
EP3488851A1 (en) * 2018-10-03 2019-05-29 AVM Biotechnology, LLC Immunoablative therapies
KR20220148859A (ko) * 2020-02-28 2022-11-07 에이브이엠 바이오테크놀로지, 엘엘씨 림프구 집단 및 이를 생산하는 방법

Similar Documents

Publication Publication Date Title
Zhang et al. CAR-T cell therapy in multiple myeloma: Current limitations and potential strategies
Zhou et al. Liver-resident NK cells control antiviral activity of hepatic T cells via the PD-1-PD-L1 axis
Zhang et al. Treg: a promising immunotherapeutic target in oral diseases
Xia et al. Activated regulatory T-cells attenuate myocardial ischaemia/reperfusion injury through a CD39-dependent mechanism.
Almawi et al. An alternate mechanism of glucocorticoid anti‐proliferative effect: promotion of a Th2 cytokine‐secreting profile
Letafati et al. Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications
Wang et al. Regulatory T cells in autoimmune hepatitis: unveiling their roles in mouse models and patients
Gross et al. Regulatory functions of natural killer cells in multiple sclerosis
Cerwenka et al. Natural killer cell memory in infection, inflammation and cancer
Kin et al. It takes nerve to tell T and B cells what to do
Li et al. The role of immune cells in chronic HBV infection
Earle et al. In vitro expanded human CD4+ CD25+ regulatory T cells suppress effector T cell proliferation
Noble et al. IFN-γ and IL-4 regulate the growth and differentiation of CD8+ T cells into subpopulations with distinct cytokine profiles
Morgan et al. Distinct effects of dexamethasone on human natural killer cell responses dependent on cytokines
Calzada-Wack et al. Interleukin-10 drives human monocytes to CD16 positive macrophages
Qu et al. Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients
Thomson et al. Prospective clinical testing of regulatory dendritic cells in organ transplantation
JP2020515581A5 (cg-RX-API-DMAC7.html)
Luo et al. CMV infection and CMV-specific immune reconstitution following haploidentical stem cell transplantation: an update
Murphy et al. The potential role of NK cells in the separation of graft‐versus‐tumor effects from graft‐versus‐host disease after allogeneic bone marrow transplantation
KR20000010799A (ko) 억제인자 세포 집단을 생성시키기 위한 인터루킨-10의 용도
Varanasi et al. Azacytidine treatment inhibits the progression of herpes stromal keratitis by enhancing regulatory T cell function
Ye et al. Optimization of donor lymphocyte infusion for AML relapse after allo-HCT in the era of new drugs and cell engineering
Duan et al. Targeting NK cells for HIV-1 treatment and reservoir clearance
Khil et al. Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice